These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26315830)

  • 1. Predictive Value of 99mTc-MAA SPECT for 90Y-Labeled Resin Microsphere Distribution in Radioembolization of Primary and Secondary Hepatic Tumors.
    Ilhan H; Goritschan A; Paprottka P; Jakobs TF; Fendler WP; Todica A; Bartenstein P; Hacker M; Haug AR
    J Nucl Med; 2015 Nov; 56(11):1654-60. PubMed ID: 26315830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of absorbed doses to the tumoral and non-tumoral liver in HCC patients undergoing
    Noipinit N; Sukprakun C; Siricharoen P; Khamwan K
    Ann Nucl Med; 2024 Mar; 38(3):210-218. PubMed ID: 38142421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of the Tumor-to-Normal Ratio for Radioembolization of Hepatocellular Carcinoma: A Prospective Study Comparing 2-Dimensional Perfusion Angiography, Technetium-99m Macroaggregated Albumin, and Yttrium-90 SPECT/CT.
    Brunson CP; McGregor HJ; Hennemeyer CT; Patel MV; Woodhead GJ; Young SJ
    J Vasc Interv Radiol; 2024 Jan; 35(1):94-101. PubMed ID: 37783268
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Tabotta F; Gnesin S; Dunet V; Ponti A; Digklia A; Boughdad S; Schaefer N; Prior JO; Villard N; Tsoumakidou G; Denys A; Duran R
    Sci Rep; 2023 Aug; 13(1):13118. PubMed ID: 37573346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPECT and CT misregistration reduction in [
    Lu Z; Chen G; Jiang H; Sun J; Lin KH; Mok GSP
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2319-2330. PubMed ID: 36877236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Dosimetry and Outcomes of Hepatocellular Carcinoma Treated by Yttrium-90 Resin Microsphere Radioembolization: A Retrospective Analysis Using Technetium-99m Macroaggregated Albumin SPECT/CT and Planning Software.
    Doyle PW; Workman CS; Grice JV; McGonigle TW; Huang S; Borgmann AJ; Baker JC; Duncan DP; Taylor JE; Brown DB
    J Vasc Interv Radiol; 2024 May; 35(5):689-698.e3. PubMed ID: 38246416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting the net administered activity in
    Henry EC; Lopez B; Mahvash A; Thomas MA; Kappadath SC
    Med Phys; 2023 Nov; 50(11):7003-7015. PubMed ID: 37272198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung Mean Dose Prediction in Transarterial Radioembolization (TARE): Superiority of [
    Wagemans MEHM; Braat AJAT; van Rooij R; Smits MLJ; Bruijnen RCG; Prince JF; Bol GM; de Jong HWAM; Lam MGEH
    Cardiovasc Intervent Radiol; 2024 Apr; 47(4):443-450. PubMed ID: 38326577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors modulating
    Lopez BP; Mahvash A; Long JP; Lam MGEH; Kappadath SC
    J Appl Clin Med Phys; 2022 Dec; 23(12):e13734. PubMed ID: 35906892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct comparison and reproducibility of two segmentation methods for multicompartment dosimetry: round robin study on radioembolization treatment planning in hepatocellular carcinoma.
    Lam M; Garin E; Palard-Novello X; Mahvash A; Kappadath C; Haste P; Tann M; Herrmann K; Barbato F; Geller B; Schaefer N; Denys A; Dreher M; Fowers KD; Gates V; Salem R
    Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):245-257. PubMed ID: 37698645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partition Dosimetry and Outcomes of Metastatic Neuroendocrine Tumors after Yttrium-90 Resin Microsphere Radioembolization.
    Doyle PW; Workman CS; Grice JV; McGonigle TW; Huang S; Borgmann AJ; Baker JC; Taylor JE; Brown DB
    J Vasc Interv Radiol; 2024 May; 35(5):699-708. PubMed ID: 37871833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EANM dosimetry committee series on standard operational procedures: a unified methodology for
    Chiesa C; Sjogreen-Gleisner K; Walrand S; Strigari L; Flux G; Gear J; Stokke C; Gabina PM; Bernhardt P; Konijnenberg M
    EJNMMI Phys; 2021 Nov; 8(1):77. PubMed ID: 34767102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing
    Maxwell AWP; Mendoza HG; Sellitti MJ; Camacho JC; Deipolyi AR; Ziv E; Sofocleous CT; Yarmohammadi H; Maybody M; Humm JL; Schwartz J; Juluru K; Dunphy MP; Boas FE
    Cardiovasc Intervent Radiol; 2022 Jul; 45(7):958-969. PubMed ID: 35459960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishing Updated Safety Standards for Independent
    Kim TP; Gandhi RT; Tolakanahalli R; Herrera R; Chuong MD; Gutierrez AN; Alvarez D
    Int J Radiat Oncol Biol Phys; 2024 Jul; 119(4):1285-1296. PubMed ID: 38925768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver Tumor Enhancement at Hybrid Angio-CT and Comparison With Tumor and Hepatic Parenchymal Distribution of Yttrium-90 Microspheres by Positron Emission Tomography.
    Campbell GS; Reed DK; Desai A; T Lirette S
    Cureus; 2023 Dec; 15(12):e49861. PubMed ID: 38169929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive Partition Dosimetry and Outcomes after Yttrium-90 Resin Microsphere Radioembolization of Colorectal Cancer Metastatic to the Liver: A Retrospective Analysis.
    Doyle PW; Workman CS; Shah N; McGonigle TW; Grice JV; Huang S; Borgmann AJ; Baker JC; Guys NP; Taylor JE; Brown DB
    J Vasc Interv Radiol; 2023 Dec; 34(12):2138-2146. PubMed ID: 37640105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma.
    Li Q; Wang X; Li D; Liu Y; Liu K; Liang J; Sun J; Jiang Q; Li J; Liu Z; Gong J; Xiang L; Jia Z; Chen Z; Cao M; Jiang Y
    J Vis Exp; 2024 May; (207):. PubMed ID: 38856215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept.
    Garin E; Lenoir L; Edeline J; Laffont S; Mesbah H; Porée P; Sulpice L; Boudjema K; Mesbah M; Guillygomarc'h A; Quehen E; Pracht M; Raoul JL; Clement B; Rolland Y; Boucher E
    Eur J Nucl Med Mol Imaging; 2013 Jul; 40(7):1057-68. PubMed ID: 23613103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres.
    Levillain H; Bagni O; Deroose CM; Dieudonné A; Gnesin S; Grosser OS; Kappadath SC; Kennedy A; Kokabi N; Liu DM; Madoff DC; Mahvash A; Martinez de la Cuesta A; Ng DCE; Paprottka PM; Pettinato C; Rodríguez-Fraile M; Salem R; Sangro B; Strigari L; Sze DY; de Wit van der Veen BJ; Flamen P
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1570-1584. PubMed ID: 33433699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Early Versus Delayed Hepatic Artery Perfusion Scan on
    Kovan B; Denizmen D; Civan C; Kuyumcu S; Isik EG; Has Simsek D; Ozkan ZG; Poyanli A; Demir B; Sanli Y
    Cancer Biother Radiopharm; 2024 Jun; 39(5):330-336. PubMed ID: 38265813
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.